Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jinlin Hou (J Hou)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical and translational hepatology

Journal of viral hepatitis

Hepatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Harry L A Janssen, Jinlin Hou, Asselah Tarik, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection. Gut (2023)
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns-Georg Klein, Johannes Kolja Hegel, Kairat Madin, Konstantin Kroeniger, Ashish Sharma, Henry Lik Yuen Chan
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies. Hepatology communications 7 (11) (2023)
Mengqi Luo, Jia Hou, Haoming Mai, Jiaxuan Chen, Haitao Chen, Bin Zhou, Jinlin Hou, De-Ke Jiang
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients. Alimentary pharmacology & therapeutics 56 (5) (2022)
Zhihong Liu, Qinglong Jin, Yuexin Zhang, Guozhong Gong, Guicheng Wu, Lvfeng Yao, Xiaofeng Wen, Zhiliang Gao, Yan Huang, Daokun Yang, Enqiang Chen, Qing Mao, Shide Lin, Jia Shang, Huanyu Gong, Lihua Zhong, Huafa Yin, Fengmei Wang, Peng Hu, Qiong Wu, Chao Pan, Wen Jia, Chuan Li, Chang'an Sun, Junqi Niu, Jinlin Hou, null null
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients. Journal of clinical and translational hepatology 11 (3) (2022)
Zhihua Liu, Zhongdan Chen, Fuqiang Cui, Yang Ding, Yunfei Gao, Guorong Han, Jidong Jia, Jie Li, Zengde Li, Yingxia Liu, Qing Mao, Ailing Wang, Wei Wang, Lai Wei, Jianhong Xia, Qing Xie, Xizhong Yang, Xueru Yin, Hua Zhang, Liaoyun Zhang, Wenhong Zhang, Hui Zhuang, Xiaoguang Dou, Jinlin Hou
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022). Journal of clinical and translational hepatology 10 (5) (2022)
Kin Seng Liem, Heng Chi, Scott Fung, David K Wong, Colina Yim, Seham Noureldin, Jiayun Chen, Robert A de Man, Arif Sarowar, Jordan J Feld, Bettina E Hansen, Jinlin Hou, Jie Peng, Harry L A Janssen
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B. Journal of viral hepatitis 29 (11) (2022)
Young-Suk Lim, Wai Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao, Jinlin Hou, Stuart C Gordon, John F Flaherty, Leland J Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data. Alimentary pharmacology & therapeutics 55 (8) (2022)
Zhihong Liu, Qinglong Jin, Yuexin Zhang, Guozhong Gong, Guicheng Wu, Lvfeng Yao, Xiaofeng Wen, Zhiliang Gao, Yan Huang, Daokun Yang, Enqiang Chen, Qing Mao, Shide Lin, Jia Shang, Huanyu Gong, Lihua Zhong, Huafa Yin, Fengmei Wang, Peng Hu, Qiong Wu, Chao Pan, Wen Jia, Chuan Li, Chang'an Sun, Junqi Niu, Jinlin Hou, null null
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients. Journal of clinical and translational hepatology 11 (3) (2022)
Xieer Liang, Qing Xie, Jia Shang, Hong Tang, Min Xu, Qinghua Meng, Jiming Zhang, Pujun Gao, Jifang Sheng, Hao Wang, Jidong Jia, Guiqiang Wang, Shunquan Wu, Jingna Ping, Jinlin Hou
Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: is monotherapy enough? Journal of gastroenterology and hepatology (2021)
Rong Fan, Junqi Niu, Hong Ma, Qing Xie, Jun Cheng, Huiying Rao, Xiaoguang Dou, Jianping Xie, Wei Zhao, Jie Peng, Zhiliang Gao, Hongbo Gao, Xinyue Chen, Jinjun Chen, Qiang Li, Hong Tang, Zhengang Zhang, Hong Ren, Mingliang Cheng, Xieer Liang, Chaonan Zhu, Lai Wei, Ji-Dong Jia, Jian Sun, Jinlin Hou, null null
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy. Alimentary pharmacology & therapeutics 54 (3) (2021)
Weijia Han, Jinlin Hou
Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Rong Fan, Jinlin Hou
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' reply. Alimentary pharmacology & therapeutics 54 (5) (2021)
Muye Xia, Heng Chi, Yaobo Wu, Bettina E Hansen, Zhandong Li, Shi Liu, GuiChan Liao, Xiaoyong Zhang, Bin Zhou, Jinlin Hou, Jian Sun, Harry L A Janssen, Jie Peng
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment. Alimentary pharmacology & therapeutics 54 (5) (2021)
Zhihong Liu, Qinglong Jin, Yuexin Zhang, Guozhong Gong, Guicheng Wu, Lvfeng Yao, Xiaofeng Wen, Zhiliang Gao, Yan Huang, Daokun Yang, En-Qiang Chen, Qing Mao, Shide Lin, Jia Shang, Huanyu Gong, Lihua Zhong, Huafa Yin, Fengmei Wang, Peng Hu, Ling Xiao, Chuan Li, Qiong Wu, Chang'an Sun, Junqi Niu, Jinlin Hou, null null
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 54 (9) (2021)
Bin Zhou, Weimeng He, Jinlin Hou
HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein? Hepatology international 14 (6) (2020)
Shi Liu, Zhihong Liu, Wanying Li, Bin Zhou, Xieer Liang, Rong Fan, Rui Deng, Jinlin Hou, Jian Sun
Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues. Alimentary pharmacology & therapeutics 52 (4) (2020)
Haitao Chen, Jian Sun, Bin Zhou, Jinxin Peng, Qing Xie, Xieer Liang, Rong Fan, Carly Conran, Jianfeng Xu, Yuan Ji, Xinxin Zhang, Li Sun, Ji-Dong Jia, Guiqiang Wang, Jinlin Hou, De-Ke Jiang
A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients. Alimentary pharmacology & therapeutics 51 (4) (2020)
Xiaoyong Zhang, Suwen Lu, Hui Li, Yi Wang, Zhen Lu, Zhihong Liu, Qingtao Lai, Yali Ji, Xuan Huang, Yongyin Li, Jian Sun, Yingsong Wu, Xiaoning Xu, Jinlin Hou
Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study. Virologica Sinica 35 (6) (2020)
Jian Sun, X Liang, R Fan, Jinlin Hou
Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C-can one size fit all? Alimentary pharmacology & therapeutics 47 (6) (2019)
Yan Wang, X Liang, J Yang, H Wang, D Tan, S Chen, J Cheng, Y Chen, Jian Sun, F Rong, W Yang, H Liu, Z Liu, Y Zheng, J Liang, S Li, Z Liu, Jinlin Hou
Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B. Journal of viral hepatitis 25 (5) (2017)
X Liang, Q Xie, D Tan, Q Ning, J Niu, X Bai, S Chen, J Cheng, Y Yu, H Wang, M Xu, G Shi, M Wan, X Chen, H Tang, J Sheng, X Dou, J Shi, Hong Ren, M Wang, H Zhang, Z Gao, C Chen, H Ma, Y Chen, R Fan, Jian Sun, J Jia, Jinlin Hou
Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study. Journal of viral hepatitis 25 (3) (2017)

Jinlin Hou.css-eqlu8i{font-size:small;padding-left:4px;} (J Hou)

Publication Activity (10 Years)

Top Topics

Top Venues

Jinlin Hou (J Hou)